Skincare Ingredient Science and Derm Studies — 2026-09-16
The skincare industry is shifting focus toward "blue peptides" and genetic-level interventions, as highlighted by recent Korean launches and Japanese product trends. Meanwhile, the first US products containing the newly FDA-approved UV filter bemotrizinol are beginning to reach shelves, marking the end of a 27-year regulatory freeze.
Skincare Ingredient Science and Derm Studies — 2026-09-16
Top developments
TOUN28 Launches "Blue Peptide" Anti-Aging Concept
On September 11, 2026, Korean brand TOUN28 unveiled its "2026 TOUN28 2.0 UNPACK : THE FIRST BLUE" event in Seoul, introducing "blue peptide" as a successor to PDRN (Polydeoxyribonucleotide) and retinol. The company positions this ingredient as a shift from simply supplying active ingredients to inducing the skin's own inherent activity for anti-aging. This move reflects a broader trend in K-beauty where ingredient narratives are evolving from exogenous supply to endogenous activation
Bemotrizinol Sunscreen Products Reach US Market
Following the FDA's approval of bemotrizinol (BEMT) in June 2026, the first US products containing this new UV filter are now appearing on shelves. Drug Topics reported that dsm-firmenich's Parsol Shield and Ultra Violette have launched formulations incorporating the ingredient. Bemotrizinol is the first new sunscreen active ingredient approved by the FDA since 1999, offering broad-spectrum protection with low skin absorption
Argireline Claims Scrutinized for Wrinkle Reduction
A new report published 12 hours ago by Women's Health Mag examines the peptide argireline, often marketed as "Botox in a bottle." While some studies suggest it can reduce wrinkles by up to 52% in four weeks, dermatologists caution that results vary significantly compared to injectable treatments. The article highlights the gap between marketing claims and clinical reality for topical neuropeptides
Amorepacific Pivots to Derma and Clinical Skincare
Amorepacific announced on September 14, 2026, that it will accelerate its global expansion strategy by focusing on derma-beauty, clinical skincare, and hair care. This strategic pivot aims to support the group's goal of reaching 15 trillion KRW in revenue by 2035. The move signals a major industry shift where traditional beauty conglomerates are increasingly betting on science-backed, dermatological-grade portfolios to drive growth
Local view
In South Korea, media outlets like Bio Times and FToday are closely covering the rise of "blue peptides" as a novel anti-aging mechanism, framing it as a departure from the previous dominance of PDRN. In Japan, VOCE reported on September 14, 2026, about "gene-level skin revolutions" in the upcoming Autumn/Winter skincare lineups, indicating a consumer appetite for high-tech, biologically targeted ingredients. The Japanese beauty magazine LIPS continues to feature extensive reviews of retinol-peptide hybrid serums, such as VT's "Retinal Peptide Serum," reflecting the local market's strong preference for multi-functional active combinations
Context & numbers
- Regulatory Milestone: Bemotrizinol was added to the FDA's permitted sunscreen list on June 9, 2026, ending a 27-year freeze on new OTC sunscreen ingredients in the US. Companies were permitted to incorporate it into products starting August 9, 2026
- Amorepacific Target: The Korean beauty giant has set a revenue target of 15 trillion KRW by 2035, with derma and clinical skincare identified as key growth engines alongside its flagship brand Sulwhasoo
On the radar
- BEYOND BEAUTY TOKYO 2026: The exhibition is scheduled for September 30 – October 2, 2026, at Tokyo Big Sight, where next-generation beauty ingredients will be showcased.
- Cosmetic Science Journal: The September issue of the Japanese cosmetic research journal Cosmetic Science was released recently, likely containing updated technical data on local ingredient developments.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
